Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Chemical/toxin
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseChemical/toxinC57BL/6Malen = Carbon tetrachloride experiment 60 mice in six groups of 10…Oral gavage (methylprednisolone intraperitoneal)3, 15 and 75 mg/kg (3 mg/kg in the carbon tetrachloride exp…Pretreatment, with injury induced on the third day alongside the final dose
Model: Two acute hepatitis models: carbon tetrachloride 100 microlitres/kg intraperitoneally in olive oil with sacrifice at 24 hours, and concanavalin A 10 mg/kg intravenously with sacrifice at 8 hours
The extract gave marked dose-dependent protection in the carbon tetrachloride model, with AST down 91% and ALT down 88% at 75 mg/kg, but had no significant effect in the concanavalin A model.
Extraction: extract · Supplied extraction confidence: 0.93. Machine-extracted fields require source verification.